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Summary: In this paper we present a method for determining the iron saturation of ferritin as a possible indepen-
dent predictor of iron stores. Serum ferritin was purified by immunochemical precipitation, and could be completely
recovered from serum without any contamination from transferrin. The iron content of the precipitated ferritin was
determined by flameless atomic absorption spectrophotometry (FAAS) and the ferritin-iron saturation was calculated
using the original serum ferritin concentration. The intra- and inter-assay variation coefficients were 4.2% and
13.4% respectively.
The first results with this assay indicate that serum ferritin contains a considerable amount of iron. Furthermore the
results show that the iron saturation of ferritin in patients with acute phase response is significantly lower than the
saturation found in healthy volunteers (19.3% and 24.3% respectively). These results suggest a possible role for the
ferritin-iron saturation in the assessment of iron stores in patients suffering from acute phase response. In addition,
the considerable amount of iron in ferritin suggests the need to revise the physiological role of this substance in
relation to the serum iron homeostasis.
Introduction
For the determination of the iron status in anaemic pa-
tients several indicators can be used, such as serum iron,
transferrin, transferrin iron binding capacity and ferritin.
Ferritin is the method of choice to estimate the iron
stores. It has been proposed that circulating ferritin may
act as a transport protein for iron between the reticulo-
endothelial cells and the erythron, but the reported low
iron contents of serum ferritin, even in iron overload
states, makes this unlikely (1, 2). Several authors de-
monstrated the existence of ferritin receptors on the sur-
face of erythrons and macrophages, however the func-
tion of these receptors is still unknown (3—4). With this
in mind we were interested in the iron content of se-
rum ferritin.
Ferritin acts as a positive acute phase reactant. There-
fore, especially in chronic disease, the measurement of
ferritin is not a reliable analyte for assessing the iron
stores. Iron deficiency can be obscured by high ferritin
concentrations due to the acute-phase response. The fer-
ritin level in serum may also be increased due to liver
cell damage or to malignancies. Witte et al. (6, 7) sug-
gested that ferritin concentrations, if corrected for the
acute phase response, could still be used to estimate the
iron stores in bone marrow, even in patients with chronic
disease. The applied nomograms describing the relation
between ferritin concentration and C-reactive protein or
erythrocyte sedimentation rate values, in order to diag-
nose or exclude iron deficiency anaemia in patients with
chronic disease. This was done in an effort to minimize
the numbers of bone marrow examination needed. In our
institute the data of Witte et al. (6, 7), were not con-
firmed by Coenen et al. (8).
Recently, new efforts were undertaken to tackle this
problem. A working hypothesis was formulated: In the
case of inflammation and iron deficiency anaemia, the
iron content of the increased level of ferritin is low.
To test this hypothesis a simple method had to be devel-
oped in order to determine the iron content of serum fer-
ritin.
This paper deals with the description of this technique
and gives the first results obtained with this method.
During the European Iron Club meeting in Hamburg in
September last year, part of these results were pre-
sented (9).
Materials and Methods
Flameless atomic absorption measurements were performed on a
Perkin Elmer (Uberlingen, Germany) model 3030 spectrophotome-
ter with deuterium background correction, equipped with a
PE HGA500 graphite furnace atomizer (programmable) and a
PE AG40 autosampler. The iron hollow cathode lamp was from
Instrumentation Laboratories (Palermo, Italy) no. 89225. Instru-
mental conditions are summarized in table 1.
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Tab. 1 Instrumental conditions for the determination of iron by
flameless atomic absorption spectrophotometry
Sample volume 20 μΐ
Fe hollow cathode lamp 30 mA
Slit width 0.2 nm, alternate
Wavelength 248.3 nm
Deuterium background detector on graphite furnace tube with
L 'vov platform, pyrolytic coated
Purge gas, argon: 330 ml/min
Calibration auto select
Iron standards 0, 25, 50, and 100 μ§/1
Dry cycle
Char cycle
Atomize
Clean
Cool
130 °C
250 °C
850 °C
1400 °C
1400 °C
2400 °C
2700 °C
20 °C
10 s ramp
10 s ramp
5 s ramp
5 s ramp
1 s ramp
0 s ramp
1 s ramp
1 s ramp
20 s hold
5 s hold
5 s hold
5 s hold
5 s hold1
5 s hold12
3 s hold
20 s hold
1
 Gas flow interrupt
2
 Signal processing, peak area, 5 s after start atomizer cycle
Calibration mixtures were prepared from a ferric nitrate standard
solution 1 g/1, Spectrosol, BDH Chemicals) in 200 mmol/1 nitric
acid.
The ferritin assay was performed on the Stratus fluorometric ana-
lyzer using the Stratus ferritin fluorometric enzyme immunoassay-
kit (B5700-56, Baxter Diagnostics Inc., Deerfield, IL, USA) ac-
cording to the manufacturers protocol.
Beads coated with anti-ferritin antibodies were from Biorad (Quan-
tirnmune®-Ferritin-IRMA, Biorad, Clinical Division, Hercules,
CA, USA). Before use the beads were washed in S0rensen buffer,
in order to remove the radioactively labelled antibodies, and stored
at 4 °C.
The iron content of ferritin is determined as follows: 300 μΐ serum
(with known ferritin concentration, not more than 1000 μg/l) are
combined with an overestimate of 300 μΐ beads in an iron-free
glass tube, and incubated for 30 minutes. The beads are separated
from the supernatant by centrifugation (10 minutes at 3000 min~').
Subsequently the beads are washed three times with 300 μΐ 9 g/l
saline at 4 °C. Bidistilled water (300 μΐ) is added to the beads
followed by an incubation of 60 minutes at 90 °C in a water-bath.
After a 10 minute centrifugation (3000 min"1) the iron content of
the supernatant is determined with flameless AAS.
An experiment was performed to establish the washing procedure
and the results are shown in table 2. From these results it can be
concluded that after three washings most of the serum iron is re-
moved and that the losses of ferritin and iron are acceptable.
Calculation of the ferritin iron saturat ion
The relative molecular mass of ferritin is 450 000, while the total
number of iron molecules per molecule ferritin is reported to be
around 4500 (1). The maximal amount of iron is taken as 100%.
Thus, a ferritin concentration of χ μg/l and an iron concentration
in the ferritin of y \igl\, gives a saturation percentage (z%) of:
[(y / 55.8) / {(x / 450000) X 4500}] X 100% = z%
Results
Ferritin isolation from serum
In figure 1 the results are shown from an experiment
in which a serum sample was incubated with beads
coated with anti-ferritin antibodies. Ferritin removal
from the serum is 100%, while the transfemn concen-
tration is unaffected. The isolated ferritin is removed
from the beads by heating at 90 °C 60 minutes; to
estimate the iron content of the ferritin the iron
content of the supernatant is determined by FAAS. In
order to estimate whether all iron was removed from
the beads, an experiment was performed in which the
denaturation procedure with the ferritin coated beads
with diluted (0.24 mol/1) HNO3 was compared to the
aqua dest. denaturation. Denaturation of the beads with
HNO3 did result in iron concentrations of the superna-
tant comparable to the denaturation with aqua dest.,
indicating that the removal of the iron is complete
(data not shown). The ferritin content of the beads
equals the content of the original serum sample be-
cause of the 100% removal of the ferritin from the
serum (fig. 1). The intra- and inter-assay coefficients
of variation of the new technique, described in this
paper, were found to be satisfactory (4.2% and 13.4%
respectively; tab. 3).
Tab. 2 Representative experiment of iron measurement in ferri-
tin, in which the ferritin and iron losses during the several washing
procedures are measured.
Wash- Ferritin Iron
ings concentration concentration
in washing in washing
solutions solutions
Iron
concentration
in solution after
denaturation
0*
1
2
3
4
5
0.9
3.3
7.5
3.3
2.8
2.3
550
182
61
17
9
5
100
33
11
3
2
1
75
59
52
51
56
48
* Serum
200 400 600
Amount of beads [μΐ]
Fig. 1 Transfemn and ferritin concentration as a percentage of
the initial value in a serum sample incubated with increasing
amounts of anti-ferritin antibody coated beads.
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Tab. 3 Intra- and inter-assay coefficients of variation of the iron
content in ferritin.
Intra-assay CV1
4.2%
Inter-assay CV2
13.4%
Mean iron value: 108 μ^Ι
SD: 4.6 μ§/1
Mean iron value: 101 μ§/1
SD: 12.0 μ§/1
1
 In one series of measurements the same sample was determined
10 times.
2
 On 10 consecutive days the same sample was measured once
a day.
Linearity of the assay
The linearity of the assay was estimated by stepwise
dilution (with saline) of a sample from a known
haemochromatosis patient. The results are shown in
figure 2. The linearity was acceptable until the Fe
concentration dropped below 10 μ§/1. So at a satura-
tion of 20%, the detection limit of this ferritin assay
was found to be 100 μ§/1. In order to exclude matrix
effects a serum sample with a very low ferritin con-
centration was used as a diluent, the results were
comparable (data not shown).
Preliminary patient data
The ferritin iron saturation in the serum of 10 healthy
male volunteers was measured. The iron saturation of
ferritin was also determined in a group of 47 patients
selected on the basis of a high erythrocyte sedimentation
rate. Table 4 shows the comparison between healthy vol-
unteers and patients with an acute phase reaction. From
the range it can be seen that the iron ferritin saturation
percentages vary from 5 to 50%, so the amount of iron
in ferritin is considerable. Furthermore these data sug-
gest that in patients with an acute phase reaction the iron
saturation of ferritin is statistically significantly
(p < 0.05) lower than in healthy controls.
120
Fig. 2
cate.
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Ferritin concentration [μς/Ι]
Linearity of the assay. Each point is measured in tripli-
Discussion
The iron saturation of ferritin was found to be rather
high, up to 50%. A ferritin concentration of 200 μg/l
with an iron content of 40% contributes around 6% to
the total serum iron concentration. The biological role
of this considerable amount of circulating iron store still
has to be elucidated. However, a dynamic role for serum
ferritin with respect to iron transport is not unlikely
since the presence of ferritin receptors on lymphoid and
erythroid cells has been known for many years (3—5,
10, 11). In addition Meyron-Holtz et al. (4) recently re-
ported that ferritin bound to its receptor is internalized
and may be important as a donor of iron in erythroid
cells.
Earlier investigations describe lower saturation percent-
ages of ferritin, 2.5 — 11% molar percentages (12—15).
The method presented in this paper is much more direct
than the methods which were applied by earlier investi-
gators. They may have lost iron from the ferritin during
laborious and time consuming-chromatographic isola-
tion procedures, using elution buffers without iron. Her-
bert et al. (16) recently published an abstract in which
they reported iron saturation percentages of 11—50%,
which is in line with our results.
With the technique presented here it will be possible to
study the ferritin iron saturation in various pathological
conditions, such as patients with anaemia and chronic
disease. The preliminary data obtained with patients
having acute phase response are in line with our working
hypothesis that the iron saturation of ferritin is lower in
these patients. The results described in this paper are
supported by the work of Herbert et al. (16), who stated
in their abstract that inflammation is characterized by an
increased number of ferritin molecules each containing
a "subnormal" quantity of iron.
Ferritin molecules are composed of 24 subunits. A com-
mon structure of most ferritin protein molecules is the
composition of different ratios of the primary ferritin
subunit chains: the L (light) subunit MT19 500 and the H
(heavy) subunit Mr 21 000 (17). It is known that ferritin
synthesis under influence of acute phase cytokines such
Tab. 4 Iron saturation of ferritin in 47 patients having an acute
phase reaction, compared to 10 healthy volunteers.
Healthy
volunteers
(n - 10)
Patients with
acute phase
(n = 47)
Ferritin concentration
mean (SD)
Iron saturation of ferritin
(%) mean (SD)
(range)
111.8(81.6)
24.3 (8.2)"
(11-37)
445.2 (56.6)
19.3 (7.4)"
(5-42)
* significant difference ρ < 0.05 (Students t test)
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as the interleukins (IL) IL-l , IL-6 and tumour necrosis
factor-α (TNF-α) is more in favour of the H subunit,
while under influence of iron both subunits are up-regu-
lated (18). If such a shift is considered during the acute
response in our group of patients, theoretically a maxi-
mum shift would result in Mr of 504 000 (24 H subun-
its). This means an increase in MT of 8%, which results
in an increase of the calculated iron saturation of ferritin
of 8%. This may compensate for the observed decrease
of iron-saturation of ferritin of 5% (tab. 4) in this group
of patients, although such a dramatic shift in isoforms is
unlikely. Glycosylation could have been another disturb-
ing factor, since it is known that serum ferritin is also
composed of a glycosylated subunit (Mr 23 000). How-
ever we do not have to take this into account because
the serum ferritin and liver- and spleen ferritin, in the
applied assay, react in the same way (manufacturers'
information). This indicates that the epitopes used in this
assay are unaffected by glycosylation.
The group of patients which were investigated was very
heterogenous with respect to the cause of the acute
phase response. Further investigation on patients with
well-defined conditions causing an acute phase re-
sponse, for instance rheumatoid arthritis, are necessary
to prove the value of this method in clinical practice.
Instead of a bone marrow biopsy, the iron saturation of
the ferritin may also be helpful in assessing the iron
stores of patients with anaemia and chronic disease. At
the moment this work is in progress in our institute.
Furthermore the ferritin iron saturation is of interest
when dealing with haemochromatosis patients with re-
spect to the monitoring of therapy. Further insight into
the kinetics of iron transport and storage processes may
help in the diagnosis and follow-up of iron deficiency,
while the role of ferritin as a transporter of iron has to
be reconsidered.
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